Mikeluna (carteolol/latanoprost) / Otsuka, Senju Pharmaceutical - LARVOL DELTA

OPC-1085EL in the Treatment of Primary Open Angle Glaucoma or Ocular Hypertension in Chinese Subjects (clinicaltrials.gov) - P3 | N=204 | Completed | Sponsor: Otsuka Beijing Research Institute | Recruiting ➔ Completed | Trial completion date: Apr 2024 ➔ Dec 2024 | Trial primary completion date: Mar 2024 ➔ Nov 2024

Trial completion • Trial completion date • Trial primary completion date • Cardiovascular • Glaucoma • Ophthalmology

Effect of treatment with carteolol and latanoprost in newly diagnosed primary open-angle glaucoma on peripapillary vessel density. (PubMed, Biomed Pap Med Fac Univ Palacky Olomouc Czech Repu) - "Carteolol had a better effect on vessel density than latanoprost."

Journal • Glaucoma • Ophthalmology